IP Library Granted Patent US 9,279,092
Granted Patent B2
US 9,279,092 · App. 14/503,367 · Granted Mar 8, 2016

Estolide and lubricant compositions that contain ene and Diels Alder compounds

Inventors: Jeremy Forest (Honolulu, HI); Jakob Bredsguard (Lake Forest, CA); Travis Thompson (Anaheim, CA)
Assignee: Biosynthetic Technologies, LLC
C10M105/36C10M169/04C10M2207/281C10M2207/282C10M2207/301C10N2220/022C10N2220/023C10N2220/024C10N2230/02C10N2270/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,279,092
App. No.
14/503,367
Granted
Mar 8, 2016
Kind
B2
Abstract

Provided herein are compositions containing at least one estolide compound and at least one ene and/or Diels Alder compound. In certain embodiments, the addition of at least one ene and/or Diels Alder compound to an estolide-containing composition may improve the cold temperature, viscometric, and/or anti-wear properties of the composition.

Claims (46)

1. A composition comprising:

at least one estolide compound; and

at least one compound selected from compounds of Formula I:

wherein

X is selected from optionally substituted C 2 to C 12 alkylene that is saturated or unsaturated, and branched or unbranched;

X′ and Y′, independently for each occurrence, are selected from an optionally substituted alkylene that is saturated or unsaturated, and branched or unbranched;

Y is selected from optionally substituted C 1 to C 20 alkyl that is saturated or unsaturated, and branched or unbranched;

U and U′, independently for each occurrence, are selected from hydrogen and —C(═O)OR 7 , wherein at least one of U and U′ is selected from —C(═O)OR 7 ; and

R 7 and R 8 , independently for each occurrence, are selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched,

wherein the dashed line represents a single bond or a double bond.

2. The composition according to claim 1 , wherein X is selected from C 7 alkylene and C 8 alkylene.

3. The composition according to claim 1 , wherein X is selected from C 10 alkylene and C 11 alkylene.

4. The composition according to claim 1 , wherein X is unsubstituted, unbranched, and saturated.

5. The composition according to claim 1 , wherein Y is selected from C 5 alkyl and C 6 alkyl.

6. The composition according to claim 1 , wherein Y is selected from C 8 alkyl and C 9 alkyl.

7. The composition according to claim 1 , wherein Y is unsubstituted, unbranched, and saturated.

8. The composition according to claim 1 , wherein X′ is selected from optionally substituted C 5 to C 10 alkylene that is saturated or unsaturated, and branched or unbranched.

9. The composition according to claim 8 , wherein U′ is hydrogen.

10. The composition according to claim 8 , wherein U′ is selected from —C(═O)OR 7 .

11. The composition according to claim 8 , wherein X′ is unsubstituted, unbranched, and saturated.

12. The composition according to claim 1 , wherein Y′ is selected from optionally substituted C 5 to C 10 alkylene that is saturated or unsaturated, and branched or unbranched.

13. The composition according to claim 12 , wherein U is hydrogen.

14. The composition according to claim 12 , wherein U is selected from —C(═O)OR 7 .

15. The composition according to claim 12 , wherein Y′ is unsubstituted unbranched and saturated.

16. The composition according to claim 1 , wherein the dashed line represents a single bond.

17. The composition according to claim 1 , wherein R 7 and R 8 , independently for each occurrence, are selected from unsubstituted C 1 to C 20 alkyl that is saturated, and branched or unbranched.

18. The composition according to claim 1 , wherein the at least one estolide compound is selected from compounds of Formula V:

wherein

x is, independently for each occurrence, an integer selected from 0 to 20;

y is, independently for each occurrence, an integer selected from 0 to 20;

n is an integer greater than or equal to 0;

R 1 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is an optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue of said at least one estolide compound is independently optionally substituted.

19. The composition according to claim 18 , wherein

x is, independently for each occurrence, an integer selected from 1 to 10;

y is, independently for each occurrence, an integer selected from 1 to 10;

n is an integer selected from 0 to 8;

R 1 is an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched; and

R 2 is an optionally substituted C 1 to C 22 alkyl that is saturated or unsaturated, and branched or unbranched,

wherein each fatty acid chain residue is unsubstituted.

20. The composition according to claim 18 , wherein R 2 is selected from C 6 to C 12 alkyl.

21. The composition according to claim 20 , wherein R 2 is 2-ethylhexyl.

22. The composition according to claim 18 , wherein R 1 is a branched or unbranched C 1 to C 20 alkyl that is saturated or unsaturated.

23. The composition according to claim 18 , wherein x is an integer selected from 7 and 8.

24. The composition according to claim 23 , wherein y is an integer selected from 7 and 8.

Assignments (6)
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK OIL ADDITIVES USA, INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045684/0293 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: BP TECHNOLOGY VENTURES INC.
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045688/0600 →
ASSIGNMENT OF SECURITY INTEREST Recorded Mar 23, 2018
From: EVONIK CORPORATION
To: BIOSYN HOLDINGS, LLC
Reel/Frame 045860/0547 →
SECURITY INTEREST Recorded Jan 30, 2018
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: BP TECHNOLOGY VENTURES INC.
Reel/Frame 045196/0587 →
SECURITY INTEREST Recorded Mar 18, 2016
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK OIL ADDITIVES USA, INC.
Reel/Frame 038146/0859 →
SECURITY INTEREST Recorded Nov 30, 2015
From: BIOSYNTHETIC TECHNOLOGIES, LLC
To: EVONIK CORPORATION
Reel/Frame 037162/0364 →
Continuity (3)
Continuation 14073537 · Nov 6, 2013
Provisional Application 61728108 · Nov 19, 2012
Related Publication 20150087569A1 · Mar 26, 2015